Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
143.2 USD | +0.14% | +3.66% | +8.38% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.38% | 14.39B | |
-1.33% | 104B | |
+4.20% | 97.47B | |
+5.82% | 22.25B | |
-13.41% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-11.72% | 16.36B | |
+41.43% | 12.37B | |
+301.83% | 8.43B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Raymond James Adjusts Price Target on Neurocrine Biosciences to $145 From $135, Maintains Outperform Rating